BMS Japan on Track to Achieve Goals in Mid-Term Biz Plan: Chief

BMS Japan President and CEO Jean-Christophe Barland The Japan arm of Bristol Myers Squibb is “on track” to achieve its mid-term business plan dubbed “Japan 2023 (J-23)” as scheduled, local helmsman Jean-Christophe Barland said on July 13 in a speech...read more